Home

T. Rowe Price Investment Management reported a 14.7% stake in Cytokinetics CYTK · 17,602,440 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
14.7%
Last report
11.3% · filed 25/05/07
Shares held
17,602,440 sh
Class
COMMON STOCK
Event date
25/06/30
Filed
25/08/14

14.7% stake · +3.4pp from the last report

Stake
14.7%
Last report
11.3%
Since last report
+3.4pp

Cytokinetics trades, last 26 weeks

What else happened in Cytokinetics around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

T. Rowe Price Investment Management's other 5% stake reports